September 30 September 30
--------------------- ---------------------
Segmented Information 2007 2006 2007 2006
-------------------------------------------------------------------------
Revenue
Nucryst Pharmaceuticals $ 7,839 $ 8,203 $ 20,656 $ 22,451
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Operating loss
Nucryst Pharmaceuticals $ (195) $ (2,638) $ (4,167) $ (9,016)
iFire Technology (8,358) (8,443) (26,982) (28,731)
Other (including
corporate costs) (4,194) 229 (8,979) (4,817)
-------------------------------------------------------------------------
Operating loss $ (12,747) $ (10,852) $ (40,128) $ (42,564)
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Consolidated September December
Balance Sheets 30, 2007 31, 2006
------------------------------------------------
Cash and short-term
investments $ 32,645 $ 62,832
Current assets 51,247 80,256
Other assets 64,099 68,083
Current liabilities 13,701 15,797
Shareholders' equity 82,680 112,977
| SOURCE Westaim Corporation Copyright©2007 PR Newswire. All rights reserved |